Ameriprise Financial Inc. Sells 213,328 Shares of Validus Holdings, Ltd. (VR)

Ameriprise Financial Inc. trimmed its holdings in Validus Holdings, Ltd. (NYSE:VR) by 59.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 146,510 shares of the insurance provider’s stock after selling 213,328 shares during the period. Ameriprise Financial Inc. owned about 0.18% of Validus worth $7,211,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. IFP Advisors Inc lifted its position in shares of Validus by 14.0% during the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock valued at $112,000 after purchasing an additional 265 shares in the last quarter. State of Wisconsin Investment Board lifted its position in shares of Validus by 2.7% during the second quarter. State of Wisconsin Investment Board now owns 15,379 shares of the insurance provider’s stock valued at $799,000 after purchasing an additional 400 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Validus during the second quarter worth about $116,000. Bank of New York Mellon Corp increased its holdings in Validus by 1.9% during the second quarter. Bank of New York Mellon Corp now owns 307,542 shares of the insurance provider’s stock worth $15,982,000 after buying an additional 5,878 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in Validus by 4.2% during the second quarter. Legal & General Group Plc now owns 68,219 shares of the insurance provider’s stock worth $3,546,000 after buying an additional 2,760 shares during the last quarter. 96.24% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms recently issued reports on VR. Barclays decreased their price objective on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating for the company in a report on Monday, October 16th. ValuEngine downgraded shares of Validus from a “buy” rating to a “hold” rating in a report on Wednesday, October 11th. Zacks Investment Research upgraded shares of Validus from a “strong sell” rating to a “hold” rating in a report on Thursday, October 5th. Keefe, Bruyette & Woods restated a “hold” rating and set a $51.00 price objective on shares of Validus in a report on Thursday, October 12th. Finally, Buckingham Research began coverage on shares of Validus in a report on Monday, September 11th. They set a “buy” rating and a $52.00 price objective for the company. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $54.83.

In other news, CEO Lixin Zeng sold 26,136 shares of Validus stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $52.10, for a total value of $1,361,685.60. Following the completion of the transaction, the chief executive officer now owns 57,855 shares in the company, valued at $3,014,245.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Kean Driscoll sold 6,875 shares of Validus stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $46.16, for a total transaction of $317,350.00. Following the completion of the transaction, the president now owns 110,858 shares of the company’s stock, valued at approximately $5,117,205.28. The disclosure for this sale can be found here. Insiders sold 39,886 shares of company stock valued at $2,024,848 in the last quarter. Corporate insiders own 2.33% of the company’s stock.

Validus Holdings, Ltd. (NYSE VR) opened at $46.91 on Tuesday. The firm has a market cap of $3,710.07, a PE ratio of -72.17 and a beta of 0.67. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95. Validus Holdings, Ltd. has a 12 month low of $41.15 and a 12 month high of $58.76.

Validus (NYSE:VR) last posted its earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, topping the consensus estimate of ($3.30) by $0.08. The firm had revenue of $407.00 million during the quarter, compared to the consensus estimate of $453.04 million. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. The company’s revenue was up 24.3% on a year-over-year basis. During the same quarter last year, the company earned $1.02 earnings per share. equities research analysts expect that Validus Holdings, Ltd. will post -0.24 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be paid a $0.38 dividend. The ex-dividend date is Thursday, December 14th. This represents a $1.52 annualized dividend and a dividend yield of 3.24%. Validus’s payout ratio is -233.84%.

COPYRIGHT VIOLATION WARNING: “Ameriprise Financial Inc. Sells 213,328 Shares of Validus Holdings, Ltd. (VR)” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.com-unik.info/2017/12/26/ameriprise-financial-inc-sells-213328-shares-of-validus-holdings-ltd-vr.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Institutional Ownership by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit